INTEGRATED BIOPHARMA INC - 8-K Filing

Integrated BioPharma reports Q3 2026 revenue decline to $9.9 million and a net loss of $0.7 million. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 13, 2026, 17:12 UTC

Tickers: $INBP

Read the full article at SEC EDGAR

More Regulatory news

Yinfu Gold Corp. - 10-Q Filing SEC EDGAR · November 13, 2026, 17:17 UTC
CROSS TIMBERS ROYALTY TRUST - 10-Q Filing SEC EDGAR · November 13, 2026, 17:14 UTC
Rare Earths Americas, Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 17:00 UTC
AVAI BIO, INC. - 10-Q Filing SEC EDGAR · November 13, 2026, 16:57 UTC
DYADIC INTERNATIONAL INC - 8-K Filing SEC EDGAR · November 13, 2026, 16:57 UTC
INTEGRATED BIOPHARMA INC - 10-Q Filing SEC EDGAR · November 13, 2026, 16:52 UTC
PCS Edventures!, Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 16:49 UTC
Royale Energy, Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 16:46 UTC
Blue Chip Capital Group Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 16:34 UTC
MOVING iMAGE TECHNOLOGIES INC. - 10-Q Filing SEC EDGAR · November 13, 2026, 16:28 UTC